IAG Capital Partners is a venture capital firm that leads early-stage to growth-stage rounds, providing flexible equity and debt financing to help innovative companies in advanced computing, life sciences, and medical technology scale their operations.
About IAG Capital Partners
IAG Capital Partners is a Tulsa-based investment firm with a generalist private equity and venture orientation, including selective exposure to healthcare services and tech-enabled healthcare businesses. Public information is limited and the firm operates primarily on family-office capital rather than as a traditional institutional VC fund. Plausible check sizes are $1M to $10M depending on stage, with the firm comfortable in Series A through growth rounds and willing to do control and minority deals. Healthcare exposure is partial and historical, with prior investments in healthcare services, real estate, and selectively healthcare technology. AI focus is undeclared and not a stated thesis. Founders best suited are commercial-stage CEOs in healthcare services or tech-enabled services with revenue, who are looking for patient capital and a partner comfortable with longer hold periods than typical VC. Founders who do not fit include pre-revenue digital health teams, therapeutics, devices, and AI labs without commercial traction. Geographic preference appears to be Oklahoma and the broader US South-Central region, with selective national investments. The entry path is warm introduction through a portfolio executive, a regional banker, or a Tulsa-area operator, with LinkedIn outreach to a principal as a secondary option for founders with strong fit and clear regional rationale. Founders should expect a deliberate, evidence-driven diligence process and an investor that prizes downside protection.
Founder reviews
Healthcare AI tools backed by IAG Capital Partners
Tools made by companies in IAG Capital Partners's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in IAG Capital Partners's portfolio not currently in our directory.
- Cognito Therapeutics · 2023
- Lucid Scientific · 2023
- PercAssist · 2026
- Baebies
- Coagulo
- Elucid
- First Ascent Biomedical
- Fluid Biomed
- Leuko
- Ordau014ds
Pitch / review this investor
Have you raised from IAG Capital Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).